<?xml version="1.0" encoding="UTF-8"?><REUTERS CGISPLIT="TRAINING-SET" LEWISSPLIT="TEST" NEWID="18118" OLDID="7563" TOPICS="NO">
<DATE> 2-JUN-1987 12:21:18.45</DATE>
<TOPICS/>
<PLACES><D>usa</D></PLACES>
<PEOPLE/>
<ORGS/>
<EXCHANGES/>
<COMPANIES/>
<UNKNOWN> 
   F
   f1730 reute
d f BC-IMMUNOMEDICS-&lt;IMMU.O&gt;   06-02 0059</UNKNOWN>
<TEXT> 
<TITLE>IMMUNOMEDICS &lt;IMMU.O&gt; HAS NEW LINKER TECHNOLOGY</TITLE>
<DATELINE>    NEWARK, N.J., June 2 - </DATELINE><BODY>Immunomedics Inc said it has
developed a technology that makes it possible to join chemical
molecules to antibodies in a more selective manner than now
possible.
    It said it has filed a patent application, which is
expected to be issued shortly as a patent for the technology.
 Reuter
 </BODY></TEXT>
</REUTERS>